Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXL1 | hg38_v1_chr16_+_86578543_86578555 | 0.75 | 3.1e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_91180365 Show fit | 3.65 |
ENST00000547937.5
|
decorin |
|
chr3_+_157436842 Show fit | 3.35 |
ENST00000295927.4
|
pentraxin 3 |
|
chr12_-_91179472 Show fit | 2.93 |
ENST00000550099.5
ENST00000546391.5 |
decorin |
|
chr1_+_163068775 Show fit | 2.81 |
ENST00000421743.6
|
regulator of G protein signaling 4 |
|
chr2_+_151357583 Show fit | 2.74 |
ENST00000243347.5
|
TNF alpha induced protein 6 |
|
chr2_+_188974364 Show fit | 2.51 |
ENST00000304636.9
ENST00000317840.9 |
collagen type III alpha 1 chain |
|
chr1_+_163069353 Show fit | 2.35 |
ENST00000531057.5
ENST00000527809.5 ENST00000367908.8 ENST00000367909.11 |
regulator of G protein signaling 4 |
|
chr13_-_37598750 Show fit | 2.25 |
ENST00000379743.8
ENST00000379742.4 ENST00000379749.8 ENST00000379747.9 ENST00000541179.5 ENST00000541481.5 |
periostin |
|
chr2_-_68319887 Show fit | 2.19 |
ENST00000409862.1
ENST00000263655.4 |
cannabinoid receptor interacting protein 1 |
|
chr12_-_91153149 Show fit | 2.02 |
ENST00000550758.1
|
decorin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 12.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 5.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 3.8 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
1.1 | 3.4 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
0.5 | 3.3 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 3.0 | GO:0051923 | sulfation(GO:0051923) |
0.5 | 2.8 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.4 | 2.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 2.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 2.2 | GO:1990523 | bone regeneration(GO:1990523) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 12.5 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 6.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.8 | 4.0 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.0 | 3.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 2.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 2.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 2.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 1.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 1.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.3 | GO:0030478 | actin cap(GO:0030478) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 12.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 5.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 4.0 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 3.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 3.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 3.1 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 3.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 2.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 2.5 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 2.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 15.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 7.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 4.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 3.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 2.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 2.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 2.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 12.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 5.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 4.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 4.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 3.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 2.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |